Citations (42)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Yara Mouhamed, Andrey Vishnyakov, Bessi Qorri, Manpreet Sambi, SM Signy Frank, Catherine Nowierski, Anmol Lamba, Umrao Bhatti & Myron R Szewczuk. (2018) Therapeutic potential of medicinal marijuana: an educational primer for health care professionals. Drug, Healthcare and Patient Safety 10, pages 45-66.
Read now
Read now
Gregory L. Sahlem, Rachel L. Tomko, Brian J. Sherman, Kevin M. Gray & Aimee L. McRae-Clark. (2018) Impact of cannabis legalization on treatment and research priorities for cannabis use disorder. International Review of Psychiatry 30:3, pages 216-225.
Read now
Read now
Articles from other publishers (40)
Gregory L. Sahlem, Bohye Kim, Nathaniel L. Baker, Brendan L. Wong, Margaret A. Caruso, Lauren A. Campbell, Irakli Kaloani, Brian J. Sherman, Tiffany J. Ford, Ahmad H. Musleh, Jane P. Kim, Nolan R. Williams, Andrew J. Manett, Ian H. Kratter, Edward B. Short, Terese K. Killeen, Mark S. George & Aimee L. McRae-Clark. (2024) A preliminary randomized controlled trial of repetitive transcranial magnetic stimulation applied to the left dorsolateral prefrontal cortex in treatment seeking participants with cannabis use disorder. Drug and Alcohol Dependence 254, pages 111035.
Crossref
Crossref
Sherry A. McKee & Aimee L. McRae-Clark. (2022) Consideration of sex and gender differences in addiction medication response. Biology of Sex Differences 13:1.
Crossref
Crossref
Jason P. Connor, Daniel Stjepanović, Alan J. Budney, Bernard Le Foll & Wayne D. Hall. (2022) Clinical management of cannabis withdrawal. Addiction 117:7, pages 2075-2095.
Crossref
Crossref
Dimy Fluyau, Paroma Mitra, Ankit Jain, Vasanth Kattalai Kailasam & Christopher G. Pierre. (2022) Selective serotonin reuptake inhibitors in the treatment of depression, anxiety, and post-traumatic stress disorder in substance use disorders: a Bayesian meta-analysis. European Journal of Clinical Pharmacology 78:6, pages 931-942.
Crossref
Crossref
Anees Bahji, Arthi Chinna Meyyappan, Emily R Hawken & Philip G. Tibbo. (2021) Pharmacotherapies for cannabis use disorder: A systematic review and network meta-analysis. International Journal of Drug Policy 97, pages 103295.
Crossref
Crossref
Rachel Lees, Lindsey A. Hines, Deepak Cyril D'Souza, George Stothart, Marta Di Forti, Eva Hoch & Tom P. Freeman. (2021) Psychosocial and pharmacological treatments for cannabis use disorder and mental health comorbidities: a narrative review. Psychological Medicine 51:3, pages 353-364.
Crossref
Crossref
Kathleen T. Brady, Frances R. Levin, Marc Galanter & Herbert D. KleberChristina Brezing, Souparno Mitra & Frances Levin. 2021. The American Psychiatric Association Publishing Textbook of Substance Use Disorder Treatment. The American Psychiatric Association Publishing Textbook of Substance Use Disorder Treatment.
John J. Mariani, Martina Pavlicova, C. Jean Choi, Cale Basaraba, Kenneth M. Carpenter, Amy L. Mahony, Daniel J. Brooks, Adam Bisaga, Nasir Naqvi, Edward V. Nunes & Frances R. Levin. (2021) Quetiapine treatment for cannabis use disorder. Drug and Alcohol Dependence 218, pages 108366.
Crossref
Crossref
Nicolas Arnaud, Tobias Banaschewski, Frauke Nees, Verena Nadine Bucholz, Michael Klein, Olaf Reis, Tanja Legenbauer, Antonia Zapf & Rainer Thomasius. (2020) Achtsamkeit in der entwicklungsorientierten Suchtprävention und -therapie: Rational, Design und Ziele des Forschungsverbundes IMAC-Mind. Praxis der Kinderpsychologie und Kinderpsychiatrie 69:4, pages 353-374.
Crossref
Crossref
Karli K. KondoBenjamin J. MorascoShannon M. NugentChelsea K. AyersMaya E. O'NeilMichele FreemanDevan Kansagara. (2020) Pharmacotherapy for the Treatment of Cannabis Use Disorder. Annals of Internal Medicine 172:6, pages 398.
Crossref
Crossref
Rachel L. Tomko, Nathaniel L. Baker, Caitlyn O. Hood, Amanda K. Gilmore, Erin A. McClure, Lindsay M. Squeglia, Aimee L. McRae-Clark, Susan C. Sonne & Kevin M. Gray. (2019) Depressive symptoms and cannabis use in a placebo-controlled trial of N-Acetylcysteine for adult cannabis use disorder. Psychopharmacology 237:2, pages 479-490.
Crossref
Crossref
Margaret Haney, Ziva D. Cooper, Gillinder Bedi, Evan Herrmann, Sandra D. Comer, Stephanie Collins Reed, Richard W. Foltin & Frances R. Levin. (2018) Guanfacine decreases symptoms of cannabis withdrawal in daily cannabis smokers. Addiction Biology 24:4, pages 707-716.
Crossref
Crossref
Pamela Sabioni & Bernard Le Foll. (2019) Psychosocial and Pharmacological Interventions for the Treatment of Cannabis Use Disorder. FOCUS 17:2, pages 163-168.
Crossref
Crossref
Suzanne Nielsen, Linda Gowing, Pamela Sabioni & Bernard Le Foll. (2019) Pharmacotherapies for cannabis dependence. Cochrane Database of Systematic Reviews 2020:3.
Crossref
Crossref
Dustin C. Lee, Nicolas J. Schlienz, Erica N. Peters, Robert H. Dworkin, Dennis C. Turk, Eric C. Strain & Ryan Vandrey. (2019) Systematic review of outcome domains and measures used in psychosocial and pharmacological treatment trials for cannabis use disorder. Drug and Alcohol Dependence 194, pages 500-517.
Crossref
Crossref
Tomislav Majić, Stefan Gutwinski, Christian A. Müller, Nikola Schoofs & Andreas Heinz. 2019. Suchtmedizin. Suchtmedizin
81
90
.
Itai Danovitch & David A. Gorelick. 2019. The Assessment and Treatment of Addiction. The Assessment and Treatment of Addiction
105
121
.
Brian J. Sherman & Aimee L. McRae-Clark. 2019. Cannabis Use Disorders. Cannabis Use Disorders
207
211
.
Suzanne Nielsen, Pamela Sabioni, Linda Gowing & Bernard Le Foll. 2020. Substance Use Disorders. Substance Use Disorders
355
372
.
Christiane Baldus, Laura Mokros, Anne Daubmann, Nicolas Arnaud, Martin Holtmann, Rainer Thomasius & Tanja Legenbauer. (2018) Treatment effectiveness of a mindfulness-based inpatient group psychotherapy in adolescent substance use disorder - study protocol for a randomized controlled trial. Trials 19:1.
Crossref
Crossref
Annie Lévesque & Bernard Le Foll. (2018) When and How to Treat Possible Cannabis Use Disorder. Medical Clinics of North America 102:4, pages 667-681.
Crossref
Crossref
Pamela Sabioni & Bernard Le Foll. (2018) Psychosocial and pharmacological interventions for the treatment of cannabis use disorder. F1000Research 7, pages 173.
Crossref
Crossref
Christina A Brezing & Frances R Levin. (2017) The Current State of Pharmacological Treatments for Cannabis Use Disorder and Withdrawal. Neuropsychopharmacology 43:1, pages 173-194.
Crossref
Crossref
M. Hesse & B. Thylstrup. 2017. Handbook of Cannabis and Related Pathologies. Handbook of Cannabis and Related Pathologies
1066
1073
.
A.L. McRae-Clark. 2017. Handbook of Cannabis and Related Pathologies. Handbook of Cannabis and Related Pathologies
1030
1035
.
Mariana P. Halah, Michelle P. Zochniak, Mera S. Barr & Tony P. George. (2016) Cannabis Use and Psychiatric Disorders: Implications for Mental Health and Addiction Treatment. Current Addiction Reports 3:4, pages 450-462.
Crossref
Crossref
Lisa Walther, Andreas Gantner, Andreas Heinz & Tomislav Majiić. (2016) Evidence-based Treatment Options in Cannabis Dependency. Deutsches Ärzteblatt international.
Crossref
Crossref
Brian J. Sherman, Nathaniel L. Baker & Aimee L. McRae-Clark. (2016) Gender differences in cannabis use disorder treatment: Change readiness and taking steps predict worse cannabis outcomes for women. Addictive Behaviors 60, pages 197-202.
Crossref
Crossref
Birgitte Thylstrup & Morten Hesse. (2016) Impulsive lifestyle counseling to prevent dropout from treatment for substance use disorders in people with antisocial personality disorder: A randomized study. Addictive Behaviors 57, pages 48-54.
Crossref
Crossref
Brittany L. Mason, Alaa Mustafa, Francesca Filbey & E. Sherwood Brown. (2016) Novel Pharmacotherapeutic Interventions for Cannabis Use Disorder. Current Addiction Reports 3:2, pages 214-220.
Crossref
Crossref
Brian J. Sherman & Aimee L. McRae-Clark. (2016) Treatment of Cannabis Use Disorder: Current Science and Future Outlook. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 36:5, pages 511-535.
Crossref
Crossref
Aimee L. McRae-Clark, Nathaniel L. Baker, Kevin M. Gray, Therese Killeen, Karen J. Hartwell & Susan J. Simonian. (2016) Vilazodone for cannabis dependence: A randomized, controlled pilot trial. The American Journal on Addictions 25:1, pages 69-75.
Crossref
Crossref
L.V. Panlilio, Z. Justinova, J.M. Trigo & B. Le Foll. 2016. Animal Models for Medications Screening to Treat Addiction. Animal Models for Medications Screening to Treat Addiction
87
120
.
Aimee L. McRae-Clark, Nathaniel L. Baker, Kevin M. Gray, Therese K. Killeen, Amanda M. Wagner, Kathleen T. Brady, C. Lindsay DeVane & Jessica Norton. (2015) Buspirone treatment of cannabis dependence: A randomized, placebo-controlled trial. Drug and Alcohol Dependence 156, pages 29-37.
Crossref
Crossref
Margaret Haney, Divya Ramesh, Andrew Glass, Martina Pavlicova, Gillinder Bedi & Ziva D Cooper. (2015) Naltrexone Maintenance Decreases Cannabis Self-Administration and Subjective Effects in Daily Cannabis Smokers. Neuropsychopharmacology 40:11, pages 2489-2498.
Crossref
Crossref
Y. Mashhoon, S. Sava, J.T. Sneider, L.D. Nickerson & M.M. Silveri. (2015) Cortical thinness and volume differences associated with marijuana abuse in emerging adults. Drug and Alcohol Dependence 155, pages 275-283.
Crossref
Crossref
Christian P. Müller & Judith R. Homberg. (2015) The role of serotonin in drug use and addiction. Behavioural Brain Research 277, pages 146-192.
Crossref
Crossref
Kushani Marshall, Linda Gowing, Robert Ali & Bernard Le Foll. (2014) Pharmacotherapies for cannabis dependence. Cochrane Database of Systematic Reviews.
Crossref
Crossref
Scott E. Hadland & Sion K. Harris. (2014) Youth marijuana use. Current Opinion in Pediatrics 26:4, pages 420-427.
Crossref
Crossref
Rebecca E. Balter, Ziva D. Cooper & Margaret Haney. (2014) Novel Pharmacologic Approaches to Treating Cannabis Use Disorder. Current Addiction Reports 1:2, pages 137-143.
Crossref
Crossref